📰 Stagezero Life Sciences News
Page 5 - Stagezero Life Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Stagezero Life Sciences. Real-time updates on events, politics, business and more.
May 26, 2022
Press release content from Accesswire. The AP news staff was not involved in its creation.
May 25, 2022
First-ever mRNA gene expression, multi-cancer panel simultaneously screens for multiple cancers from a single sample of bloodTORONTO, ON and RICHMOND, VA / ACCESSWIRE / May 25, 2022 / StageZero Life Sciences
May 25, 2022
Press release content from Accesswire. The AP news staff was not involved in its creation.
May 25, 2022
StageZero's Aristotle test uses mRNA technology to identify the molecular signatures of multiple cancer types.
May 17, 2022
TORONTO, ON / ACCESSWIRE / May 17, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS)(OTCQB:SZLSF), a vertically-integrated healthcare company devoted to improving the early detection
May 15, 2022
TORONTO, ON / ACCESSWIRE / May 15, 2022 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the early
May 13, 2022
TORONTO, ON / ACCESSWIRE / May 13, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that it will release its first quarter financial results before the market open
May 13, 2022
Press release content from Accesswire. The AP news staff was not involved in its creation.
April 22, 2022
Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) and StageZero Life Sciences (OTCMKTS:SZLSF – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, institutional ownership and valuation. Risk & Volatility Navidea Biopharmaceuticals has a beta […]
April 14, 2022
StageZero Life Sciences (OTCMKTS:GNWSF – Get Rating) and Alpha Teknova (NASDAQ:TKNO – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, analyst recommendations and earnings. Profitability This table compares StageZero Life Sciences and […]